ROYAL BANK OF CANADA - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 23 filers reported holding LANTERN PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$0
-100.0%
106
-48.5%
0.00%
Q2 2023$1,000206
+136.8%
0.00%
Q3 2022$0
-100.0%
87
-34.1%
0.00%
Q2 2022$1,000
-88.9%
132
-89.8%
0.00%
Q1 2022$9,0001,290
+5275.0%
0.00%
Q4 2021$024
+84.6%
0.00%
Q2 2021$0130.0%0.00%
Q1 2021$0
-100.0%
13
-98.7%
0.00%
Q4 2020$19,0000.0%1,0000.0%0.00%
Q3 2020$19,0001,0000.00%
Other shareholders
LANTERN PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 384,228$2,747,0000.54%
CM Management, LLC 33,765$241,0000.20%
WOLFF WIESE MAGANA LLC 36,155$259,0000.17%
Redmond Asset Management, LLC 49,793$356,0000.11%
CARLSON CAPITAL L P 167,300$1,196,0000.08%
NewEdge Advisors, LLC 169,771$1,214,0000.02%
Sigma Planning Corp 17,600$126,0000.00%
Spire Wealth Management 4,050$29,0000.00%
WELLS FARGO & COMPANY/MN 3,558$25,0000.00%
NORTHERN TRUST CORP 12,629$90,0000.00%
View complete list of LANTERN PHARMA INC shareholders